Logo image of DHCNL

DIVERSIFIED HEALTHCARE T - DHC 6 1/4 02/01/46 (DHCNL) Stock Fundamental Analysis

NASDAQ:DHCNL - Nasdaq - US25525P3055 - Currency: USD

14.5  0 (0%)

Fundamental Rating

2

Overall DHCNL gets a fundamental rating of 2 out of 10. We evaluated DHCNL against 129 industry peers in the Diversified REITs industry. DHCNL may be in some trouble as it scores bad on both profitability and health. DHCNL has a expensive valuation and it also scores bad on growth.


Dividend Valuation Growth Profitability Health

Quickly go to:

1

1. Profitability

1.1 Basic Checks

DHCNL had negative earnings in the past year.
In the past year DHCNL had a positive cash flow from operations.
In the past 5 years DHCNL reported 4 times negative net income.
The reported operating cash flow has been mixed in the past 5 years: DHCNL reported negative operating cash flow in multiple years.
DHCNL Yearly Net Income VS EBIT VS OCF VS FCFDHCNL Yearly Net Income VS EBIT VS OCF VS FCFYearly Net Income VS EBIT VS OCF VS FCF 2015 2016 2017 2018 2019 2020 2021 2022 2023 2024 0 200M -200M 400M -400M -600M

1.2 Ratios

DHCNL has a worse Return On Assets (-7.21%) than 89.92% of its industry peers.
With a Return On Equity value of -18.90%, DHCNL is not doing good in the industry: 86.82% of the companies in the same industry are doing better.
Industry RankSector Rank
ROA -7.21%
ROE -18.9%
ROIC N/A
ROA(3y)-4.29%
ROA(5y)-2.48%
ROE(3y)-10.69%
ROE(5y)-6.22%
ROIC(3y)N/A
ROIC(5y)N/A
DHCNL Yearly ROA, ROE, ROICDHCNL Yearly ROA, ROE, ROICYearly ROA, ROE, ROIC 2015 2016 2017 2018 2019 2020 2021 2022 2023 2024 0 5 -5 -10 -15

1.3 Margins

DHCNL's Gross Margin of 17.31% is on the low side compared to the rest of the industry. DHCNL is outperformed by 94.57% of its industry peers.
DHCNL's Gross Margin has declined in the last couple of years.
DHCNL does not have Profit Margin and Operating Margin available, so we won't be analyzing them here.
Industry RankSector Rank
OM N/A
PM (TTM) N/A
GM 17.31%
OM growth 3YN/A
OM growth 5YN/A
PM growth 3YN/A
PM growth 5YN/A
GM growth 3Y-6.33%
GM growth 5Y-20.05%
DHCNL Yearly Profit, Operating, Gross MarginsDHCNL Yearly Profit, Operating, Gross MarginsYearly Profit, Operating, Gross Margins 2015 2016 2017 2018 2019 2020 2021 2022 2023 2024 0 20 -20 40 60

More info and screens

3

2. Health

2.1 Basic Checks

DHCNL does not have a ROIC to compare to the WACC, probably because it is not profitable.
The number of shares outstanding for DHCNL has been increased compared to 1 year ago.
The number of shares outstanding for DHCNL has been increased compared to 5 years ago.
Compared to 1 year ago, DHCNL has a worse debt to assets ratio.
DHCNL Yearly Shares OutstandingDHCNL Yearly Shares OutstandingYearly Shares Outstanding 2015 2016 2017 2018 2019 2020 2021 2022 2023 2024 50M 100M 150M 200M
DHCNL Yearly Total Debt VS Total AssetsDHCNL Yearly Total Debt VS Total AssetsYearly Total Debt VS Total Assets 2015 2016 2017 2018 2019 2020 2021 2022 2023 2024 2B 4B 6B

2.2 Solvency

DHCNL has an Altman-Z score of 0.21. This is a bad value and indicates that DHCNL is not financially healthy and even has some risk of bankruptcy.
DHCNL has a Altman-Z score of 0.21. This is in the lower half of the industry: DHCNL underperforms 65.12% of its industry peers.
A Debt/Equity ratio of 1.49 is on the high side and indicates that DHCNL has dependencies on debt financing.
With a Debt to Equity ratio value of 1.49, DHCNL is not doing good in the industry: 61.24% of the companies in the same industry are doing better.
Industry RankSector Rank
Debt/Equity 1.49
Debt/FCF N/A
Altman-Z 0.21
ROIC/WACCN/A
WACC6.98%
DHCNL Yearly LT Debt VS Equity VS FCFDHCNL Yearly LT Debt VS Equity VS FCFYearly LT Debt VS Equity VS FCF 2015 2016 2017 2018 2019 2020 2021 2022 2023 2024 0 1B 2B 3B

2.3 Liquidity

DHCNL has a Current Ratio of 2.83. This indicates that DHCNL is financially healthy and has no problem in meeting its short term obligations.
DHCNL's Current ratio of 2.83 is amongst the best of the industry. DHCNL outperforms 87.60% of its industry peers.
DHCNL has a Quick Ratio of 2.83. This indicates that DHCNL is financially healthy and has no problem in meeting its short term obligations.
DHCNL has a Quick ratio of 2.83. This is amongst the best in the industry. DHCNL outperforms 87.60% of its industry peers.
Industry RankSector Rank
Current Ratio 2.83
Quick Ratio 2.83
DHCNL Yearly Current Assets VS Current LiabilitesDHCNL Yearly Current Assets VS Current LiabilitesYearly Current Assets VS Current Liabilites 2015 2016 2017 2018 2019 2020 2021 2022 2023 2024 200M 400M 600M

More info and screens

3

3. Growth

3.1 Past

The Earnings Per Share has grown by an impressive 40.57% over the past year.
The Revenue has been growing slightly by 6.04% in the past year.
Measured over the past years, DHCNL shows a small growth in Revenue. The Revenue has been growing by 7.53% on average per year.
EPS 1Y (TTM)40.57%
EPS 3YN/A
EPS 5YN/A
EPS Q2Q%116.67%
Revenue 1Y (TTM)6.04%
Revenue growth 3Y2.63%
Revenue growth 5Y7.53%
Sales Q2Q%4.34%

3.2 Future

DHCNL is expected to show quite a strong growth in Earnings Per Share. In the coming years, the EPS will grow by 16.84% yearly.
DHCNL is expected to show a small growth in Revenue. In the coming years, the Revenue will grow by 5.48% yearly.
EPS Next Y24.97%
EPS Next 2Y16.84%
EPS Next 3YN/A
EPS Next 5YN/A
Revenue Next Year4.73%
Revenue Next 2Y5.48%
Revenue Next 3YN/A
Revenue Next 5YN/A

3.3 Evolution

When comparing the Revenue growth rate of the last years to the growth rate of the upcoming years, we see that the growth is decreasing.
DHCNL Yearly Revenue VS EstimatesDHCNL Yearly Revenue VS EstimatesYearly Revenue VS Estimates 2014 2015 2016 2017 2018 2019 2020 2021 2022 2023 2024 2025 2026 500M 1B 1.5B
DHCNL Yearly EPS VS EstimatesDHCNL Yearly EPS VS EstimatesYearly EPS VS Estimates 2014 2015 2016 2017 2018 2019 2020 2021 2022 2023 2024 2025 2026 0 1 -1

More info and screens

0

4. Valuation

4.1 Price/Earnings Ratio

The Price/Earnings Ratio is negative for DHCNL. In the last year negative earnings were reported.
Besides the negative Price/Earnings Ratio, also the Forward Price/Earnings Ratio is negative for DHCNL. No positive earnings are expected for the next year.
Industry RankSector Rank
PE N/A
Fwd PE N/A
DHCNL Price Earnings VS Forward Price EarningsDHCNL Price Earnings VS Forward Price Earnings ChartPrice Earnings - Forward Price Earnings PE FPE 0 50 100

4.2 Price Multiples

DHCNL's Enterprise Value to EBITDA ratio is rather expensive when compared to the industry. DHCNL is more expensive than 92.25% of the companies in the same industry.
Industry RankSector Rank
P/FCF N/A
EV/EBITDA 26.96
DHCNL Per share dataDHCNL EPS, Sales, OCF, FCF, BookValue per sharePer Share Data Per Share 0 2 4 6 8

4.3 Compensation for Growth

DHCNL's earnings are expected to grow with 16.84% in the coming years. This may justify a more expensive valuation.
PEG (NY)N/A
PEG (5Y)N/A
EPS Next 2Y16.84%
EPS Next 3YN/A

More info and screens

1

5. Dividend

5.1 Amount

DHCNL has a Yearly Dividend Yield of 1.76%.
With a Dividend Yield of 1.76, DHCNL pays less dividend than the industry average, which is at 6.64. 88.37% of the companies listed in the same industry pay a better dividend than DHCNL!
DHCNL's Dividend Yield is slightly below the S&P500 average, which is at 2.43.
Industry RankSector Rank
Dividend Yield 1.76%

5.2 History

The dividend of DHCNL decreases each year by -45.60%.
DHCNL has been paying a dividend for over 5 years, so it has already some track record.
DHCNL has decreased its dividend in the last 3 years.
Dividend Growth(5Y)-45.6%
Div Incr Years0
Div Non Decr Years2
DHCNL Yearly Dividends per shareDHCNL Yearly Dividends per shareYearly Dividends per share 2021 2022 2023 2024 2025 0.5 1 1.5

5.3 Sustainability

The earnings of DHCNL are negative and hence is the payout ratio. DHCNL will probably not be able to sustain this dividend level.
DP-2.6%
EPS Next 2Y16.84%
EPS Next 3YN/A
DHCNL Yearly Income VS Free CF VS DividendDHCNL Yearly Income VS Free CF VS DividendYearly Income VS Free CF VS Dividend 2015 2016 2017 2018 2019 2020 2021 2022 2023 2024 0 200M -200M -400M -600M

More info and screens

DIVERSIFIED HEALTHCARE T - DHC 6 1/4 02/01/46

NASDAQ:DHCNL (5/5/2025, 8:04:43 PM)

14.5

0 (0%)

Chartmill FA Rating
GICS SectorReal Estate
GICS IndustryGroupEquity Real Estate Investment Trusts (REITs)
GICS IndustryDiversified REITs
Earnings (Last)05-05 2025-05-05/amc
Earnings (Next)07-30 2025-07-30/amc
Inst Owners75.97%
Inst Owner ChangeN/A
Ins Owners0.35%
Ins Owner ChangeN/A
Market Cap3.50B
Analysts48
Price Target20.98 (44.69%)
Short Float %0%
Short Ratio0.25
Dividend
Industry RankSector Rank
Dividend Yield 1.76%
Yearly Dividend0.04
Dividend Growth(5Y)-45.6%
DP-2.6%
Div Incr Years0
Div Non Decr Years2
Ex-Date02-14 2025-02-14 (0.390625)
Surprises & Revisions
EPS beat(2)1
Avg EPS beat(2)42.35%
Min EPS beat(2)-22.91%
Max EPS beat(2)107.62%
EPS beat(4)1
Avg EPS beat(4)8.41%
Min EPS beat(4)-27.3%
Max EPS beat(4)107.62%
EPS beat(8)3
Avg EPS beat(8)6.67%
EPS beat(12)3
Avg EPS beat(12)-9.02%
EPS beat(16)4
Avg EPS beat(16)-13.17%
Revenue beat(2)1
Avg Revenue beat(2)-0.56%
Min Revenue beat(2)-2.43%
Max Revenue beat(2)1.32%
Revenue beat(4)1
Avg Revenue beat(4)-0.81%
Min Revenue beat(4)-2.43%
Max Revenue beat(4)1.32%
Revenue beat(8)3
Avg Revenue beat(8)-0.59%
Revenue beat(12)4
Avg Revenue beat(12)-0.89%
Revenue beat(16)4
Avg Revenue beat(16)-1.46%
PT rev (1m)72.56%
PT rev (3m)-17.46%
EPS NQ rev (1m)12%
EPS NQ rev (3m)12%
EPS NY rev (1m)15.22%
EPS NY rev (3m)15.22%
Revenue NQ rev (1m)3.64%
Revenue NQ rev (3m)2.41%
Revenue NY rev (1m)1.68%
Revenue NY rev (3m)0.26%
Valuation
Industry RankSector Rank
PE N/A
Fwd PE N/A
P/S 2.34
P/FCF N/A
P/OCF 31.17
P/B 1.79
P/tB 1.79
EV/EBITDA 26.96
EPS(TTM)-0.63
EYN/A
EPS(NY)-0.67
Fwd EYN/A
FCF(TTM)-0.37
FCFYN/A
OCF(TTM)0.47
OCFY3.21%
SpS6.2
BVpS8.12
TBVpS8.12
PEG (NY)N/A
PEG (5Y)N/A
Profitability
Industry RankSector Rank
ROA -7.21%
ROE -18.9%
ROCE N/A
ROIC N/A
ROICexc N/A
ROICexgc N/A
OM N/A
PM (TTM) N/A
GM 17.31%
FCFM N/A
ROA(3y)-4.29%
ROA(5y)-2.48%
ROE(3y)-10.69%
ROE(5y)-6.22%
ROIC(3y)N/A
ROIC(5y)N/A
ROICexc(3y)N/A
ROICexc(5y)N/A
ROICexgc(3y)N/A
ROICexgc(5y)N/A
ROCE(3y)N/A
ROCE(5y)N/A
ROICexcg growth 3YN/A
ROICexcg growth 5YN/A
ROICexc growth 3YN/A
ROICexc growth 5YN/A
OM growth 3YN/A
OM growth 5YN/A
PM growth 3YN/A
PM growth 5YN/A
GM growth 3Y-6.33%
GM growth 5Y-20.05%
F-Score5
Asset Turnover0.29
Health
Industry RankSector Rank
Debt/Equity 1.49
Debt/FCF N/A
Debt/EBITDA 12.53
Cap/Depr 70.78%
Cap/Sales 13.49%
Interest Coverage N/A
Cash Conversion 48.3%
Profit Quality N/A
Current Ratio 2.83
Quick Ratio 2.83
Altman-Z 0.21
F-Score5
WACC6.98%
ROIC/WACCN/A
Cap/Depr(3y)103.34%
Cap/Depr(5y)92.72%
Cap/Sales(3y)19.78%
Cap/Sales(5y)17.46%
Profit Quality(3y)N/A
Profit Quality(5y)N/A
High Growth Momentum
Growth
EPS 1Y (TTM)40.57%
EPS 3YN/A
EPS 5YN/A
EPS Q2Q%116.67%
EPS Next Y24.97%
EPS Next 2Y16.84%
EPS Next 3YN/A
EPS Next 5YN/A
Revenue 1Y (TTM)6.04%
Revenue growth 3Y2.63%
Revenue growth 5Y7.53%
Sales Q2Q%4.34%
Revenue Next Year4.73%
Revenue Next 2Y5.48%
Revenue Next 3YN/A
Revenue Next 5YN/A
EBIT growth 1Y28.99%
EBIT growth 3YN/A
EBIT growth 5YN/A
EBIT Next Year365.69%
EBIT Next 3YN/A
EBIT Next 5YN/A
FCF growth 1Y60.15%
FCF growth 3YN/A
FCF growth 5YN/A
OCF growth 1Y970.52%
OCF growth 3YN/A
OCF growth 5Y-15.84%